AEGERION PHARMACEUTICALS INC's ticker is and the CUSIP is 00767EAB8. A total of 2 filers reported holding AEGERION PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $86,826,000 | -2.7% | 117,737,000 | 0.0% | 88.73% | +3.2% |
| Q4 2018 | $89,214,000 | -7.8% | 117,737,000 | -11.7% | 85.94% | +11.1% |
| Q3 2018 | $96,801,000 | +54.7% | 133,337,000 | +40.3% | 77.33% | +14.3% |
| Q2 2018 | $62,588,000 | -14.9% | 95,045,000 | 0.0% | 67.68% | +50.2% |
| Q1 2018 | $73,570,000 | -5.1% | 95,045,000 | 0.0% | 45.05% | -1.8% |
| Q4 2017 | $77,523,000 | – | 95,045,000 | – | 45.86% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 1,760,000 | $898,000 | 1.12% |
| Telemetry Investments, L.L.C. | 6,000,000 | $3,049,000 | 0.89% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 54,500,000 | $27,693,000 | 0.46% |
| ZAZOVE ASSOCIATES LLC | 15,070,000 | $7,761,000 | 0.37% |
| ACUTA CAPITAL PARTNERS, LLC | 1,000,000 | $508,000 | 0.28% |
| Tekla Capital Management LLC | 13,000,000 | $6,606,000 | 0.28% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 26,000,000 | $13,910,000,000 | 0.26% |
| Castle Creek Arbitrage, LLC | 4,000,000 | $2,081,000 | 0.17% |
| WOLVERINE ASSET MANAGEMENT LLC | 10,934,000 | $5,558,000 | 0.16% |
| Baker Brothers Advisors | 26,517,000 | $13,526,000 | 0.14% |